Stage IV Squamous Cell Carcinoma of the Nasopharynx Terminated Phase 2 Trials for Fosaprepitant (DB06717)

DBCOND0028783 (Stage IV Squamous Cell Carcinoma of the Nasopharynx)Terminated2 IdentifierTitlePurposeDrugs
NCT00895245Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation TherapySupportive Care